Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

BACKGROUND: Recent progress in the pathophysiology of heart failure (HF) has led to the development of new therapeutic options such as gene therapy and the use of adeno-associated viral (AAV) vectors. Despite the promising results in early clinical trials of gene therapy for HF, various obstacles ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rincon, Melvin Y, Prada, Carlos E, Lopez, Marcos, Castillo, Victor, Echeverria, Luis Eduardo, Serrano, Norma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919550/
https://www.ncbi.nlm.nih.gov/pubmed/27282359
http://dx.doi.org/10.2196/resprot.5535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919550/
https://www.ncbi.nlm.nih.gov/pubmed/27282359
http://dx.doi.org/10.2196/resprot.5535

Ejemplares similares